• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现行与以往心脏再同步治疗指南对心力衰竭患者适合接受治疗比例的影响。

Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.

机构信息

Division of Cardiology, University of Calgary, Calgary, Alberta, Canada.

Canadian VIGOUR Centre and Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.

出版信息

JACC Heart Fail. 2017 May;5(5):388-392. doi: 10.1016/j.jchf.2017.02.018.

DOI:10.1016/j.jchf.2017.02.018
PMID:28449799
Abstract

OBJECTIVES

This study sought to ascertain the impact of heart failure (HF) guideline change on the number of patients eligible to undergo cardiac resynchronization therapy (CRT).

BACKGROUND

The 2013 HF guideline of the American College of Cardiology Foundation and American Heart Association (ACCF/AHA) narrowed the recommendations for CRT. The impact of this guideline change on the number of eligible patients for CRT has not been described.

METHODS

Using data from Get With The Guidelines-Heart Failure between 2012 and 2015, this study evaluated the proportion of hospitalized patients with HF who were eligible for CRT on the basis of historical and current guideline recommendations. The authors identified 25,102 hospitalizations for HF that included patients with a left ventricular ejection fraction (LVEF) ≤35% from 283 hospitals. Patients with a medical, system-related, or patient-related reason for not undergoing CRT were excluded.

RESULTS

Overall, 49.1% (n = 12,336) of patients with HF, an LVEF ≤35%, and no documented contraindication were eligible for CRT on the basis of historical guidelines, and 33.1% (n = 8,299) of patients were eligible for CRT on the basis of current guidelines, a 16.1% absolute reduction in eligibility (p < 0.0001). Patients eligible for CRT on the basis of current guidelines were more likely to have CRT with an implantable cardioverter-defibrillator or CRT with pacing only placed or prescribed at discharge (57.8% vs. 54.9%; p < 0.0001) compared with patients eligible for CRT on the basis of historical guidelines.

CONCLUSIONS

In this population of patients with HF, an LVEF ≤35%, and no documented contraindication for CRT, the current ACCF/AHA HF guidelines reduce the proportion of patients eligible for CRT by approximately 15%.

摘要

目的

本研究旨在确定心力衰竭(HF)指南改变对符合心脏再同步治疗(CRT)条件的患者数量的影响。

背景

美国心脏病学会基金会和美国心脏协会(ACCF/AHA)2013 年 HF 指南缩小了 CRT 的推荐范围。该指南改变对 CRT 合格患者数量的影响尚未描述。

方法

本研究使用 2012 年至 2015 年 Get With The Guidelines-Heart Failure 数据库的数据,根据历史和当前指南建议评估了因 HF 住院的患者中符合 CRT 条件的比例。作者从 283 家医院中确定了 25102 例左心室射血分数(LVEF)≤35%的 HF 住院患者。排除因医疗、系统相关或患者相关原因而不能进行 CRT 的患者。

结果

总体而言,根据历史指南,49.1%(n=12336)的 HF、LVEF≤35%且无记录禁忌症的患者符合 CRT 条件,而根据当前指南,33.1%(n=8299)的患者符合 CRT 条件,符合 CRT 的资格绝对减少了 16.1%(p<0.0001)。与符合历史指南 CRT 条件的患者相比,符合当前指南 CRT 条件的患者更有可能在出院时植入式心律转复除颤器或 CRT 加起搏(57.8% vs. 54.9%;p<0.0001)。

结论

在 LVEF≤35%且无 CRT 记录禁忌症的 HF 患者中,当前的 ACCF/AHA HF 指南将符合 CRT 条件的患者比例降低了约 15%。

相似文献

1
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.现行与以往心脏再同步治疗指南对心力衰竭患者适合接受治疗比例的影响。
JACC Heart Fail. 2017 May;5(5):388-392. doi: 10.1016/j.jchf.2017.02.018.
2
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.心脏再同步治疗中左心室射血分数的正常化与室性心律失常和临床结局的风险:来自多中心自动除颤器植入试验与心脏再同步治疗(MADIT-CRT)试验的结果。
Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.
3
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.心力衰竭男性和女性心脏再同步和植入式心脏复律除颤器治疗的临床效果:来自 IMPROVE HF 的研究结果。
Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.
4
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.心脏再同步治疗超级反应的预测因素及其对临床结局的改善:MADIT-CRT(心脏再同步治疗的多中心自动除颤器植入试验)研究。
J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73. doi: 10.1016/j.jacc.2012.01.065.
5
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
6
Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.2016 年欧洲心脏病学会指南的依从性可预测需要心脏再同步治疗的心力衰竭患者的大型真实世界人群的结局。
Heart Rhythm. 2018 Nov;15(11):1675-1682. doi: 10.1016/j.hrthm.2018.04.011. Epub 2018 Apr 14.
7
Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.射血分数对轻度心力衰竭患者心脏再同步治疗临床反应的影响。
Circ Heart Fail. 2013 Nov;6(6):1180-9. doi: 10.1161/CIRCHEARTFAILURE.113.000326. Epub 2013 Sep 6.
8
The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).左心室射血分数对心脏再同步治疗效果的影响:MADIT-CRT(心脏再同步治疗的多中心自动除颤器植入试验)。
J Am Coll Cardiol. 2013 Mar 5;61(9):936-44. doi: 10.1016/j.jacc.2012.11.051.
9
Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).在轻度心力衰竭患者中(来自MADIT-CRT研究),植入式心律转复除颤器或心脏再同步化治疗除颤器之前心力衰竭住院对后续结局的时间影响
Am J Cardiol. 2015 May 15;115(10):1423-7. doi: 10.1016/j.amjcard.2015.02.029. Epub 2015 Feb 18.
10
Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).美托洛尔与卡维地洛对 MADIT-CRT(心脏再同步治疗的多中心自动除颤器植入试验)结局的影响。
J Am Coll Cardiol. 2013 Apr 9;61(14):1518-26. doi: 10.1016/j.jacc.2013.01.020.

引用本文的文献

1
Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.预测心脏再同步治疗患者心房颤动发生频率的因素。
Medicina (Kaunas). 2023 Dec 15;59(12):2178. doi: 10.3390/medicina59122178.
2
Recent successes in heart failure treatment.心力衰竭治疗的最新进展。
Nat Med. 2023 Oct;29(10):2424-2437. doi: 10.1038/s41591-023-02567-2. Epub 2023 Oct 9.
3
The role of conduction system pacing in patients with atrial fibrillation.传导系统起搏在心房颤动患者中的作用。
Front Cardiovasc Med. 2023 May 25;10:1187754. doi: 10.3389/fcvm.2023.1187754. eCollection 2023.
4
Rate or Rhythm Control in CRT (RHYTHMIC): Study rationale and protocol.心脏再同步治疗中的心率或节律控制(RHYTHMIC):研究原理与方案。
Heart Rhythm O2. 2022 Sep 13;3(6Part A):681-687. doi: 10.1016/j.hroo.2022.09.001. eCollection 2022 Dec.
5
Atrial fibrillation in cardiac resynchronization therapy.心脏再同步治疗中的心房颤动
Heart Rhythm O2. 2021 Dec 17;2(6Part B):784-795. doi: 10.1016/j.hroo.2021.09.003. eCollection 2021 Dec.
6
Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.指南对医疗技术传播的影响:以英国心脏再同步治疗为例。
Appl Health Econ Health Policy. 2021 Mar;19(2):243-252. doi: 10.1007/s40258-020-00610-8. Epub 2020 Sep 24.
7
Empirically Based Guidelines for Selecting Vagus Nerve Stimulation Parameters in Epilepsy and Heart Failure.基于经验的癫痫和心力衰竭患者迷走神经刺激参数选择指南。
Cold Spring Harb Perspect Med. 2019 Jul 1;9(7):a034264. doi: 10.1101/cshperspect.a034264.
8
Clinical outcomes with biventricular versus right ventricular pacing in patients with atrioventricular conduction defects.房室传导阻滞患者双心室起搏与右心室起搏的临床结局比较。
Heart Fail Rev. 2018 Nov;23(6):897-906. doi: 10.1007/s10741-018-9699-7.